{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-02",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "0093-3607",
      "generic_name": "Fluticasone Propionate and Salmeterol",
      "labeler_name": "Teva Pharmaceuticals USA, Inc.",
      "brand_name": "Fluticasone Propionate and Salmeterol",
      "active_ingredients": [
        {
          "name": "FLUTICASONE PROPIONATE",
          "strength": "55 ug/1"
        },
        {
          "name": "SALMETEROL XINAFOATE",
          "strength": "14 ug/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "0093-3607-82",
          "description": "1 POUCH in 1 CARTON (0093-3607-82)  / 1 INHALER in 1 POUCH / 60 POWDER, METERED in 1 INHALER",
          "marketing_start_date": "20170428",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {},
      "marketing_category": "NDA AUTHORIZED GENERIC",
      "dosage_form": "POWDER, METERED",
      "spl_id": "7d5ea703-6c3d-4ae3-be5e-a923b8c9cc21",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "RESPIRATORY (INHALATION)"
      ],
      "marketing_start_date": "20170428",
      "product_id": "0093-3607_7d5ea703-6c3d-4ae3-be5e-a923b8c9cc21",
      "application_number": "NDA208799",
      "brand_name_base": "Fluticasone Propionate and Salmeterol",
      "pharm_class": [
        "Adrenergic beta2-Agonists [MoA]",
        "Corticosteroid Hormone Receptor Agonists [MoA]",
        "Corticosteroid [EPC]",
        "beta2-Adrenergic Agonist [EPC]"
      ]
    }
  ]
}